On July 31, 2009, Marzok, Mohamed; El-Khodery, Sabry published an article.Related Products of 65896-14-2 The title of the article was Sedative and analgesic effects of romifidine in camels (Camelus dromedarius). And the article contained the following:
To evaluate the clin. effectiveness and the sedative and analgesic effects of i.v. romifidine in camels. Randomized prospective study. Eighteen healthy adult Dromedary camels. Romifidine was administered i.v. to camels (n = 6) at three different doses (40, 80 or 120 渭g/kg-1). Time of onset, degree and duration of sedation and analgesia were recorded immediately after drug administration. Heart rate, respiratory rate, ruminal contractions, muscle relaxation, response to auditory and tactile stimulation, distance between ears, distance from lower lip to the ground, and degree of ataxia were also recorded pre-administration and at 5, 15, 30, 45, 60, 90, 120, and 180 min post-administration. Plasma glucose, blood urea nitrogen and creatinine were measured. Romifidine produced dose dependent sedation and analgesia. Significant decreases in heart rate (p < 0.001), ruminal contractions (p < 0.05), distance from lower lip to the ground (p < 0.001), response to auditory and tactile stimuli (p < 0.01), and significant increases in the degree of ataxia (p < 0.01), distance between the ear tips (p < 0.001) and blood glucose (p < 0.01) concentration were recorded after administration of romifidine until recovery. However, no significant changes in rectal temperature and respiratory rate were recorded. I.v. administration of romifidine at three different doses appeared to be an effective sedative and analgesic agent for camels. Bradycardia, ruminal atony, and hyperglycemia were the most important adverse effects after i.v. administration of romifidine. The i.v. administration of romifidine at a dose rate of 120 渭g/kg-1 caused profound sedation and analgesia. Romifidine could be used for chem. restraint for a variety of diagnostic and minor surgical procedures in camels. The experimental process involved the reaction of N-(2-Bromo-6-fluorophenyl)-4,5-dihydro-1H-imidazol-2-amine hydrochloride(cas: 65896-14-2).Related Products of 65896-14-2
The Article related to camelus sedative analgesic sedivet, Pharmacology: Effects Of Nervous System- and Behavior-Affecting Drugs and Neuromuscular Agents and other aspects.Related Products of 65896-14-2
Referemce:
Imidazole – Wikipedia,
Imidazole | C3H4N2 – PubChem